Brief: Kiniksa Pharmaceuticals Provides Corporate Update
12/01/2026 12:43
Jan 12 (Reuters) - Kiniksa Pharmaceuticals International PLC KNSA.O: KINIKSA PHARMACEUTICALS PROVIDES CORPORATE UPDATE KINIKSA PHARMACEUTICALS INTERNATIONAL PLC - KPL-387 PHASE 2 DATA EXPECTED IN 2H 2026 Source text: ID:nGNX6DGLH8 Further company coverage: KNSA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiniksa Pharmaceuticals International
See all newsKiniksa Pharmaceuticals International, PLC reports results for the quarter ended June 30 - Earnings Summary
Kiniksa Pharmaceuticals Q2 product revenue rises on ARCALYST sales
Kiniksa Pharmaceuticals International, PLC expected to post earnings of 30 cents a share - Earnings Preview
Cardiovascular drugmaker Kiniksa's Q1 net income rises
Kiniksa Q4 revenue rises on ARCALYST sales